Updated review on neuromodulators

Abstract

As botulinum toxin is increasingly used cosmetically and medically, it is important to understand the differences between each formulation of this product. While the active molecule in each is a 150 kDa protein that prevents neurotransmitter release, there are currently five products FDA-approved for clinical use, with a sixth currently in its Phase 3 trial and a seventh applied under FDA review, each with different nontoxic accessory proteins and varying amounts of human serum albumin. These properties affect diffusion rates and storage methods, which are outlined in this review. Common complications and recommendations to avoid them are discussed.

Keywords

Botulinum toxin / botox / cosmetic botox / medical botox

References

[1] 2020 plastic surgery statistics report. Available from: https://www.plasticsurgery.org/documents/News/Statistics/2020/plastic-surgery-statistics-full-report-2020.pdf [Last accessed on 19 Apr 2024]

[2] Erbguth FJ.From poison to remedy: the chequered history of botulinum toxin.J Neural Transm2008;115:559-65

[3] Carruthers JD.Treatment of glabellar frown lines with C. botulinum-A exotoxin.J Dermatol Surg Oncol1992;18:17-21

[4] Whitcup SM. Botulinum toxin therapy. Springer; 2021.p.1-289.

[5] Park MY.Scientific review of the aesthetic uses of botulinum toxin type A.Arch Craniofac Surg2021;22p:1-10. PMCID:PMC7968983

[6] Bach K.The multispecialty toxin: a literature review of botulinum toxin.Plast Reconstr Surg Glob Open2022;10:e4228 PMCID:PMC8987218

[7] Coetzee S,Belaunzaran M,Stickler MA.Beyond wrinkles: a comprehensive review of the uses of botulinum toxin.J Drugs Dermatol2023;22:7243e.

[8] Martina E,Radi G,Offidani A.Therapeutic use of botulinum neurotoxins in dermatology: systematic review.Toxins2021;13:120 PMCID:PMC7915854

[9] Walker TJ.Comparison and overview of currently available neurotoxins.J Clin Aesthetic Dermatol2014;7:31-9 PMCID:PMC3935649

[10] Gassner HG,Otley CC.Botulinum toxin to improve facial wound healing: a prospective, blinded, placebo-controlled study.Mayo Clin Proc2006;81:1023-8

[11] Lewandowski M,Barańska-Rybak W.Off-label use of botulinum toxin in dermatology-current state of the art.Molecules2022;27:3143 PMCID:PMC9147387

[12] Naik PP.Utilities of botulinum toxins in dermatology and cosmetology.Clin Cosmet Investig Dermatol2021;14:1319-30 PMCID:PMC8464334

[13] Padda IS. Botulinum toxin. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557387/ [Last accessed on 19 Apr 2024]

[14] Shuo L,KeLun W,Rui Z.Efficacy and possible mechanisms of botulinum toxin treatment of oily skin.J Cosmet Dermatol2019;18:451-7

[15] Yi KH,Kim SO.Botulinum neurotoxin injection for treating plunged nose and post-rhinoplasty: anatomical perspectives of depressor septi nasi, nasalis, leveator labii superioris alaeque nasi muscle.Anat Cell Biol2023;56:409-14 PMCID:PMC10714083

[16] Fatani B.An approach for gummy smile treatment using botulinum toxin a: a narrative review of the literature.Cureus2023;15:e34032 PMCID:PMC9941039

[17] Yi KH,Hu HW.Novel anatomical proposal for botulinum neurotoxin injection targeting depressor anguli oris for treating drooping mouth corner.Anat Cell Biol2023;56:161-5 PMCID:PMC10319486

[18] Yi KH,Kim HJ.Ultrasonographic observations of the paradoxical mentalis bulging in regard to botulinum neurotoxin injection for mentalis muscle.Skin Res Technol2023;29:e13517 PMCID:PMC10616537

[19] Yi KH,Lee K,Lee HJ.Anatomical proposal for botulinum neurotoxin injection targeting the platysma muscle for treating platysmal band and jawline lifting: a review.Toxins2022;14:868 PMCID:PMC9783622

[20] Yi KH,Hu HW.Novel anatomical guidelines on botulinum neurotoxin injection for wrinkles in the nose region.Toxins2022;14:342 PMCID:PMC9144745

[21] Kontis TC. Cosmetic injection techniques: a text and video guide to neurotoxins and fillers. Thieme; 2019.p.1-226.

[22] Semchyshyn N.Botulinum toxin A treatment of perioral rhytides.Dermatol Surg2003;29:490-5; discussion 495

[23] Loyo M.Cosmetic botulinum toxin: has it replaced more invasive facial procedures?.Facial Plast Surg Clin North Am2013;21:285-98

[24] Yi KH,Hur HW,Kim HJ.Guidelines for botulinum neurotoxin injection for facial contouring.Plast Reconstr Surg2022;150:562e-71e

[25] Yi KH,Choi YJ,Lee JH.Anatomical guide for botulinum neurotoxin injection: application to cosmetic shoulder contouring, pain syndromes, and cervical dystonia.Clin Anat2021;34:822-8

[26] Phan K,Dubin D,Khorasani H.Emerging off-label esthetic uses of botulinum toxin in dermatology.Dermatol Ther2022;35:e15205

[27] Yi KH,Kim JH.Intramuscular neural distribution of the gastrocnemius for botulinum neurotoxin injection: application to cosmetic calf shaping.Yonsei Med J2023;64:511-7 PMCID:PMC10375242

[28] Galderma R&D. Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines (READY-4). Available from: https://clinicaltrials.gov/study/NCT04225260 [Last accessed on 19 Apr 2024]

[29] Frevert J.Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?.Biologics2010;4:325-32 PMCID:PMC3010823

[30] Aoki KR,Wissel J.Using translational medicine to understand clinical differences between botulinum toxin formulations.Eur J Neurol2006;13 Suppl 4:10-9

[31] Sharma SK.Immunological properties of Hn-33 purified from type A clostridium botulinum.J Nat Toxins2000;9:357-62

[32] Fabbri M,Fernandes RM.Neutralizing antibody and botulinum toxin therapy: a systematic review and meta-analysis.Neurotox Res2016;29:105-17

[33] Solish N,Kaufman J,Gross TM.Overview of DaxibotulinumtoxinA for injection: a novel formulation of botulinum toxin type a.Drugs2021;81:2091-101 PMCID:PMC8648634

[34] Frevert J.Content of botulinum neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®.Drugs RD2010;10:67-73

[35] Field M,Picaut P.AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin content and potential implications for duration of response in patients.Toxins2018;10:535 PMCID:PMC6316182

[36] Kwiat DM,Bersani A.Increased patient comfort utilizing botulinum toxin type a reconstituted with preserved versus nonpreserved saline.Ophthalmic Plast Reconstr Surg2004;20:186-9

[37] Alam M,Klein AW.Botulinum a exotoxin for hyperfunctional facial lines: where not to inject.Arch Dermatol2002;138:1180-5

[38] Gassner HG.Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study.Mayo Clin Proc2000;75:701-4

[39] Yen MT.Bupivacaine-induced myotoxicity and its effect on botulinum toxin paresis.Ann Plast Surg2008;60:6-9

[40] Borodic GE,Fay L,Ferrante RJ.Botulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread.Head Neck1990;12:392-9

[41] Arezzo JC.NeuroBloc/Myobloc: unique features and findings.Toxicon2009;54:690-6

[42] Yaraskavitch M,Herzog W.Botox produces functional weakness in non-injected muscles adjacent to the target muscle.J Biomech2008;41:897-902

[43] Eleopra R,Caniatti L.Botulinum toxin treatment in the facial muscles of humans: evidence of an action in untreated near muscles by peripheral local diffusion.Neurology1996;46:1158-60

[44] Hsu TS,Arndt KA.Effect of volume and concentration on the diffusion of botulinum exotoxin A.Arch Dermatol2004;140:1351-4

[45] Ramirez-Castaneda J,Comella C,Fernandez HH.Diffusion, spread, and migration of botulinum toxin.Mov Disord2013;28:1775-83

[46] Jensen JD,Cohen JL. Botulinum toxins. In: Draelos ZD, editor. Cosmetic Dermatology. Wiley; 2015. pp. 364-74.

[47] DailyMed. BOTOX COSMETIC - onabotulinumtoxina injection, powder, lyophilized, for solution. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=485d9b71-6881-42c5-a620-a4360c7192ab [Last accessed on 19 Apr 2024]

[48] Kassir M,Galadari H.Complications of botulinum toxin and fillers: a narrative review.J Cosmet Dermatol2020;19:570-3

[49] Witmanowski H.The whole truth about botulinum toxin - a review.Postepy Dermatol Alergol2020;37:853-61 PMCID:PMC7874868

[50] Ascher B,Cassuto D.International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part II: Wrinkles on the middle and lower face, neck and chest.J Eur Acad Dermatol Venereol2010;24:1285-95

[51] Rzany B. Safety of botulinum toxin in aesthetic medicine. In: de Maio M, Rzany B, editors. Botulinum Toxin in Aesthetic Medicine. Berlin: Springer Berlin Heidelberg; 2007. pp. 119-25.

[52] Yılmaz D,Durmaz H,Dikmen Y.The effect of duration of pressure on bruising and pain in the subcutaneous heparin injection site.Jpn J Nurs Sci 2020;17:e12325

[53] Ho B,Waldorf HA.Is there a role for arnica and bromelain in prevention of post-procedure ecchymosis or edema? a systematic review of the literature.Dermatol Surg2016;42:445-63

[54] Carruthers A.Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin.Dermatol Surg1998;24:1189-94

[55] Klein AW.Complications and adverse reactions with the use of botulinum toxin.Dis Mon2002;48:336-56

[56] Klein AW.Dilution and storage of botulinum toxin.Dermatol Surg1998;24:1179-80

[57] Carruthers A.Botulinum toxin type A: history and current cosmetic use in the upper face.Semin Cutan Med Surg2001;20:71-84

[58] Matarasso SL.Treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lip ptosis following injections to the lateral canthal rhytids.Plast Reconstr Surg2001;108:208-14; discussion 215

[59] Klein AW.Contraindications and complications with the use of botulinum toxin.Clin Dermatol2004;22:66-75

[60] Bae JH,Lee JG,Tansatit T.The risorius muscle: anatomic considerations with reference to botulinum neurotoxin injection for masseteric hypertrophy.Dermatol Surg2014;40:1334-9

[61] Klein AW.Complications and adverse reactions with the use of botulinum toxin.Semin Cutan Med Surg2001;20:109-20

[62] Blitzer A,Aviv JE,Brin MF.The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients.Arch Otolaryngol Head Neck Surg1997;123:389-92